トップページ > 研究組織一覧 > 分野・独立ユニットグループ > がん進展研究分野 > 論文業績 > 2024年
2024年
- Halik, A., Tilgner, M., Silva, P., Estrada, N., Altwasser, R., Jahn, E., Heuser, M., Hou, H. A., Pratcorona, M., Hills, R. K., Metzeler, K. H., Fenwarth, L., Dolnik, A., Terre, C., Kopp, K., Blau, O., Szyska, M., Christen, F., Kronke, J., Vasseur, L., Lowenberg, B., Esteve, J., Valk, P. J. M., Duchmann, M., Chou, W. C., Linch, D. C., Dohner, H., Gale, R. E., Dohner, K., Bullinger, L., Yoshida K., Damm, F.: Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patients. J Hematol Oncol, 17: 70 (2024).
- Noerenberg, D., Briest, F., Hennch, C., Yoshida K., Hablesreiter, R., Takeuchi, Y., Ueno, H., Staiger, A. M., Ziepert, M., Asmar, F., Locher, B. N., Toth, E., Weber, T., Amini, R. M., Klapper, W., Bouzani, M., Poeschel, V., Rosenwald, A., Held, G., Campo, E., Ishaque, N., Stamatopoulos, K., Kanellis, G., Anagnostopoulos, I., Bullinger, L., Goldschmidt, N., Zinzani, P. L., Bodor, C., Rosenquist, R., Vassilakopoulos, T. P., Ott, G., Ogawa, S., Damm, F.: Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes. J Clin Oncol, 42:452-466 (2024).
- Aoki, T., Shiba, N., Tsujimoto, S., Yamato, G., Hara, Y., Kato, S., Yoshida K., Ogawa, S., Hayashi, Y., Iwamoto, S., Taki, T., Shimada, A., Iijima-Yamashita, Y., Horibe, K., Tawa, A., Taga, T., Adachi, S., Tomizawa, D.: High IL2RA/CD25 expression is a prognostic stem cell biomarker for pediatric acute myeloid leukemia without a core-binding factor. Pediatr Blood Cancer, 71:e30803 (2024).
- Iyoda, S., Yoshida K., Shoji, K., Ito, N., Tanaka, M., Nannya, Y., Yamato, G., Tsujimoto, S., Shiba, N., Hayashi, Y., Shiozawa, Y., Shiraishi, Y., Chiba, K., Okada, A., Tanaka, H., Miyano, S., Koga, Y., Goto, H., Moritake, H., Terui, K., Ito, E., Kiyokawa, N., Tomizawa, D., Taga, T., Tawa, A., Takita, J., Nishikori, M., Adachi, S., Ogawa, S., Matsuo, H.: KRAS G12 mutations as adverse prognostic factors in KMT2A-rearranged acute myeloid leukemia. Leukemia, 38:1609-1612 (2024).
- Sato, T., Yoshida K., Toki, T., Kanezaki, R., Terui, K., Saiki, R., Ojima, M., Ochi, Y., Mizuno, S., Yoshihara, M., Uechi, T., Kenmochi, N., Tanaka, S., Matsubayashi, J., Kisai, K., Kudo, K., Yuzawa, K., Takahashi, Y., Tanaka, T., Yamamoto, Y., Kobayashi, A., Kamio, T., Sasaki, S., Shiraishi, Y., Chiba, K., Tanaka, H., Muramatsu, H., Hama, A., Hasegawa, D., Sato, A., Koh, K., Karakawa, S., Kobayashi, M., Hara, J., Taneyama, Y., Imai, C., Hasegawa, D., Fujita, N., Yoshitomi, M., Iwamoto, S., Yamato, G., Saida, S., Kiyokawa, N., Deguchi, T., Ito, M., Matsuo, H., Adachi, S. P., Hayashi, Y., Taga, T., Moriya Saito, A., Horibe, K., Watanabe, K., Tomizawa, D., Miyano, S., Takahashi, S., Ogawa, S., Ito, E.: Landscape of driver mutations and their clinical effects on Down syndrome-related myeloid neoplasms. Blood, 143:2627-2643 (2024).
